TipRanks
Go Ultimate55% OFF

Jill Marie Broadfoot Insider Profile

11 Followers

Jill Marie Broadfoot, Director at Talphera, holds 13.65K shares in Talphera (Ticker: TLPH), holds 37.30K shares in aTyr Pharma (Ticker: ATYR), holds 145.65K shares in Fresh Tracks Therapeutics (Ticker: FRTX).

Jill Marie Broadfoot's Trading History

TLPH
Talphera
Jun 24, 2026DirectorUninformative Buy―$14.06K
ATYR
aTyr Pharma
Feb 04, 2026CFOUninformative Buy2.10K$184.24K
FRTX
Fresh Tracks Therapeutics
Apr 03, 2013―Uninformative Sell147.91K$136.18K
CUE
Cue Biopharma
―Director――
OTIC
Otonomy
――――

You May Also Like

Jill Marie Broadfoot insider profile FAQ

What is the percentage of profitable transactions made by Jill Marie Broadfoot?
The percentage of profitable transactions made by Jill Marie Broadfoot is 33%.
What is the average return per transaction made by Jill Marie Broadfoot?
The average return per transaction made by Jill Marie Broadfoot is -37.50%.
What stocks does Jill Marie Broadfoot hold?
Jill Marie Broadfoot holds: TLPH, FRTX, OTIC, ATYR, CUE stocks.
What was Jill Marie Broadfoot's most profitable transaction?
Jill Marie Broadfoot’s most profitable transaction was an Informative Buy of ATYR stock on June 23, 2020. The return on the trade was 14.70%.
What is Jill Marie Broadfoot's role in Talphera?
Jill Marie Broadfoot's role in Talphera is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.